Concord Biotech makes a strong debut at D-Street, lists at 21% premium at 900.05

The IPO of Concord Biotech was sold in the range of Rs 705-741 apiece, was overall subscribed 24.87 times and was sold between August 4 to August 8.

Related Keywords

India ,Japan ,United States , ,National Stock Exchange ,Concord Biotech ,Dalal Street ,Rakesh Jhunjhunwala Backed Concord Biotech ,Concord Biotech Listing ,Concord Biotech Listing Price ,Oncord Ipo Biotech Listing ,Oncord Biotech Ipo Listing Price ,Oncord Listing ,Oncord Listing Price ,Oncord Ipo Listing ,Oncord Ipo Listing Price ,Oncord Biotech Grey Market Premium ,Oncord Biotech Ipo Grey Market Premium ,Oncord Grey Market Premium ,Oncord Ipo Grey Market Premium ,